Stock CADL CANDEL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Candel Therapeutics, Inc.

Equities

CADL

US1374041093

Market Closed - Nasdaq
Other stock markets
 03:59:44 2024-05-29 pm EDT 		5-day change 1st Jan Change
8.75 USD +2.34% Intraday chart for Candel Therapeutics, Inc. -17.30% +495.24%
May. 23 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of Can-2409 for Advanced Non-Small Cell Lung Cancer in Patients Non-Responsive to Immune Checkpoint Inhibitor Treatment At 2024 Asco Annual Meeting CI
Apr. 11 Sector Update: Health Care Stocks Decline Thursday Afternoon MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CANDEL THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+2.34%-17.30%+495.24%+503.45% - 251M
Neutral
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CADL Stock
  4. Charts Candel Therapeutics, Inc.
  5. Comparison Chart